A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer

Autor: Dueñas-Gonzalez Alfonso, Robles Elizabeth, Camargo Maria F, Candelaria Myrna, Vela Teresa, Ramirez Teresa, Villarreal Patricia, Bargallo Enrique, Taja-Chayeb Lucia, Perez-Cardenas Enrique, Trejo-Becerril Catalina, Chavez-Blanco Alma, Revilla-Vazquez Alma, de la Cruz-Hernandez Erik, Gonzalez-Fierro Aurora, Arce Claudia, Perez-Plasencia Carlos

Publikováno v: BMC Cancer, Vol 7, Iss Suppl 1, p A23 (2007)

Externí odkaz: https://doaj.org/article/7778ac3aa3e64118861932dc42e6d565

Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).

Autor: Altcheh J; Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA, Buenos Aires, Argentina., Castro L; Centro de Atencion e Investigacion Medica S.A. (CAIMED-Yopal), Yopal, Colombia., Dib JC; Universidad del Norte, Barranquilla, Colombia., Grossmann U; Bayer AG, Research and Development Pharmaceuticals, Berlin, Germany., Huang E; Bayer US LLC, Whippany, New Jersey, United States of America., Moscatelli G; Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA, Buenos Aires, Argentina., Pinto Rocha JJ; Fundación CEADES-Plataforma de Atención Integral a los Pacientes con Enfermedades de Chagas, Cochabamba, Bolivia., Ramírez TE; Centro de Enfermedad de Chagas y Patologias Regionales, Santiago del Estero, Argentina.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Jan 07; Vol. 15 (1), pp. e0008912. Date of Electronic Publication: 2021 Jan 07 (Print Publication: 2021).